These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913 [TBL] [Abstract][Full Text] [Related]
4. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer. Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618 [TBL] [Abstract][Full Text] [Related]
5. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949 [TBL] [Abstract][Full Text] [Related]
6. Palliative radiotherapy in asymptomatic patients with locally advanced, unresectable, non-small cell lung cancer. Reinfuss M; Skołyszewski J; Kowalska T; Rzepecki W; Kociołek D Strahlenther Onkol; 1993 Dec; 169(12):709-15. PubMed ID: 7506846 [TBL] [Abstract][Full Text] [Related]
7. [Late course three-dimensional conformal radiotherapy in patients with stage III non-small cell lung cancer]. Wang XC; Wang SY; Yang S; Ding Y; Shang Y Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):726-8. PubMed ID: 15958322 [TBL] [Abstract][Full Text] [Related]
8. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study. Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041 [TBL] [Abstract][Full Text] [Related]
9. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233 [TBL] [Abstract][Full Text] [Related]
10. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis. Unlu I; Diniz G; Komurcuoglu B; Gayaf M; Gokce T; Karadogan I; Akcay C Saudi Med J; 2006 Jun; 27(6):849-53. PubMed ID: 16758049 [TBL] [Abstract][Full Text] [Related]
11. Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer. Holgersson G; Bergström S; Bergqvist M; Nyman J; Hoye E; Helsing M; Friesland S; Holgersson M; Birath E; Ekman S; Blystad T; Ewers SB; Mörth C; Löden B; Henriksson R Eur J Cancer; 2011 Nov; 47(16):2415-21. PubMed ID: 21726999 [TBL] [Abstract][Full Text] [Related]
12. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Belderbos JS; Heemsbergen WD; De Jaeger K; Baas P; Lebesque JV Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):126-34. PubMed ID: 16904518 [TBL] [Abstract][Full Text] [Related]
13. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03. Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437 [TBL] [Abstract][Full Text] [Related]
14. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635 [TBL] [Abstract][Full Text] [Related]
15. Long-term survivors of non-small cell lung cancer after radiation therapy: the significance of histological type. Nakayama Y; Hayakawa K; Mitsuhashi N; Saito Y; Niibe H Anticancer Res; 1997; 17(4A):2769-73. PubMed ID: 9252713 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Nagata Y; Takayama K; Matsuo Y; Norihisa Y; Mizowaki T; Sakamoto T; Sakamoto M; Mitsumori M; Shibuya K; Araki N; Yano S; Hiraoka M Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1427-31. PubMed ID: 16169670 [TBL] [Abstract][Full Text] [Related]
17. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer. Ajlouni M; Chapman R; Kim JH Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551 [TBL] [Abstract][Full Text] [Related]
18. [The combined treatment of lung cancer with one-time large-fraction preoperative irradiation]. Kharchenko VP; Galil-Ogly GA; Chkhikvadze VD; Pan'shin GA; Goncharova IM; Sotnikov VM Vopr Onkol; 1990; 36(7):863-6. PubMed ID: 2169141 [TBL] [Abstract][Full Text] [Related]
19. [Curative radiotherapy of local advanced non-small-cell lung cancer. Eight years of experience from Odense]. Hansen O; Paarup H; Sørensen P; Hansen KH; Werenberg KA Ugeskr Laeger; 2005 Sep; 167(37):3497-502. PubMed ID: 16159459 [TBL] [Abstract][Full Text] [Related]
20. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers. Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]